Award
National Heart, Lung, and Blood Institute 11247962
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
Recipient
Boston University Medical Campus
Award Amount
$162,216.00
Ceiling
$162,216.00
Awarded
February 12, 2026
Identifier
11247962
NIH/NHLBI awarded a grant to develop an iPSC model to study alveolar type 2 cell dysfunction in pulmonary fibrosis, aiming to identify new therapeutic pathways.
Description
The project focuses on developing a patient-specific induced pluripotent stem cell (iPSC) model to study alveolar epithelial cell dysfunction in pulmonary fibrosis. The project aims to identify druggable pathways for new therapies. It is funded by NIH/NHLBI under PA-20-203 and involves collaboration with stem cell biology experts including mentored research, coursework, and presentations.